Investing in AIM discussed at a ShareSoc Masterclass. June 2015

We’ve pulled this out of the archive, from 2015. It’s still as valid today, even if the story on some of the companies cited has changed.

Insight from David Stredder, ShareSoc Director/Mello; two ISA millionaires:
Lord John Lee & Leon Boros. And Henry Evans, Fund Manager, Killik & Co.

A beginner’s guide to the difference between AIM and the main market –
Henry Evans – 1:20

Why invest in AIM? – Henry Evans – 2:35

David Stredder’s top 16 holdings (all AIM) as at June 16, and his view
on AIM – 4:08

Leon Boros’s: views on AIM – 7:30

Selection process for AIM shares? Henry Evans – 8:40

Tax advantages of AIM – Leon Boros – 9:50

What wouldn’t you touch on AIM? David Stredder – 10:35

Selection of shares: Anpario, Concurrent Technologies, Lok’n Store –
Lord Lee – 11:46

AIM regulation – Leon Boros – 14:06

What frustrates you most about AIM? David Stredder – 16:32

Enforcement of AIM rules – Henry Evans – 17:45

Q&A NOMADS – 18:40

Q&A: Averaging down – 22:28

Q&A: Is there a difference between AIM and small caps on the main
market? And, is AIM more inefficiently priced? – 29:45

 

https://www.sharesoc.org/membership/

 

Videos from ShareSoc

ECSC Group PLC investor presentation, at ShareSoc March 13.3.19, by Ian Mann, CEO.
31:47

ECSC Group plc (ECSC) Investor presentation, at ShareSoc March 13.3.19, by Ian Mann, CEO.

ECSC Group plc is a United Kingdom-based information and cyber security service provider. The Company offers a range of cyber security solutions and services to the sectors, including education, retail, legal, financial and local authorities. It offers services to e-commerce start-ups and global organisations. Its PROTECT division delivers the ECSC PCI DSS certified Security Operations […]
Avacta (AVCT) presentation at ShareSoc London 13th March 2019
37:07

Avacta (AVCT) presentation at ShareSoc London 13th March 2019

By Dr Alastair Smith, Chief Executive Shaping the Future of Cancer Therapy Dr Smith gives a comprehensive overview of Avacta, followed by Q&As. Avacta Group plc is a biotechnology company. Avacta’s focus is on its proprietary Affimer technology which is an engineered alternative to antibodies that has application in Life Sciences for diagnostics, therapeutics and […]
Forbidden Technologies (FBT) ShareSoc presentation November 2018
33:04

Forbidden Technologies (FBT) ShareSoc presentation November 2018

Forbidden Technologies (FBT) ShareSoc November presentation By Ian McDonough, CEO & Stephen Streater, Director of R&D Forbidden Technologies plc is a United Kingdom-based company engaged in the development and commercial exploitation of cloud-based video technology. The Company is engaged in developing cloud video platform used for its Forscene professional editing suite, its video social network, […]
Ilika (IKA) ShareSoc presentation November 2018
36:16

Ilika (IKA) ShareSoc presentation November 2018

Ilika (IKA) CEO Graeme Purdy and CFO Stephen Boydell give an overview of the company and an update at the ShareSoc Growth Company Seminar on the 14th November 2018. Ilika plc is the holding company. The Company is engaged in the production, design and development of high throughput methods of material synthesis, characterization and screening. […]

You might be interested in

LEAVE YOUR COMMENT

Your email address will not be published. Required fields are marked *